76 results
Page 2 of 4
424B5
80el02qamouipy7ry
1 Feb 24
Prospectus supplement for primary offering
4:49pm
424B3
7w4tkecx78q5 uad
4 Apr 23
Prospectus supplement
4:57pm
POS AM
lgeqds5v4ut0rbbo
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
DEFR14A
aswwj
22 Jun 22
Revised proxy
12:36pm
424B5
2j91xwwg92ccn51s
16 May 22
Prospectus supplement for primary offering
9:47pm
PRE 14A
afu2cq2sr
21 Apr 22
Preliminary proxy
4:33pm
S-3
EX-4.2
uip 34c4hf5u
7 Feb 22
Shelf registration
12:00am
S-3
4pwzb2v0
7 Feb 22
Shelf registration
12:00am
424B4
3l4xlmr9u5dehbq6
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
kk0pa28 hnrlxcna0
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
8-K
EX-4.1
0hwhmrtfjrxdsq00se
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am